semaglutide cardiovascular outcomes news 2025 october of and tirzepatide for patients with type 2 diabetes in clinical practice Semaglutide protects the heart beyond

Important safety considerations include contraindications in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, caution in those with a history of pancreatitis, increased risk of gallbladder disease, potential for acute kidney injury with dehydration, and possible worsening of diabetic retinopathy with rapid glycemic improvement

Yesmany people report feeling intoxicated faster and more intensely on semaglutide

Here's what we at Klinic recommend considering: Semaglutide might be better if: You have better insurance coverage for it You want a medication with a longer track record You prefer to start with something that might have a slightly gentler introduction period You'd rather take a pill than inject the Wegovy pill makes that possible You've responded well to GLP-1 medications in the past Tirzepatide might be better if: You're looking for maximum weight loss potential You want a medication developed specifically for weight loss You're willing to potentially deal with slightly more nausea initially You want a dual-action approach Your insurance covers it or you have budget flexibility Questions to ask yourself: What's your weight loss goal

Patients Seeking More Than a Blood Flow Medication Some individuals want to address emotional, psychological, or desire-related aspects of sexual dysfunction rather than focusing solely on erections or lubrication

Monteleone P, Maj M